Trials / Completed
CompletedNCT00875277
A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products
A Psoriasis Plaque Test Comparing LEO 29102 Cream and Its Different Combinations to Daivobet® Ointment and a Vehicle Control for the Treatment of Psoriasis Vulgaris
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to evaluate the anti-psoriatic effect of LEO 29102 cream and its combination with calcipotriol and betamethasone using a psoriasis plaque test method.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LEO 29102 cream | |
| DRUG | LEO 29102 Cream Vehicle | |
| DRUG | Betamethasone Dipropionate Cream | |
| DRUG | LEO 29102 Plus Calcipotriol Cream | |
| DRUG | LEO 29102 Plus Betamethasone Dipropionate | |
| DRUG | Daivobet® Ointment |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2009-05-01
- Completion
- 2009-07-01
- First posted
- 2009-04-03
- Last updated
- 2025-03-12
- Results posted
- 2019-12-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00875277. Inclusion in this directory is not an endorsement.